Literature DB >> 1528345

Low urine citrate excretion as main risk factor for recurrent calcium oxalate nephrolithiasis in males.

A Cupisti1, E Morelli, S Lupetti, M Meola, G Barsotti.   

Abstract

To better define the relative role of metabolic factors in the recurrence of stone formation, we studied the 24-hour urinary excretion of calcium (uCa), citrate (uCit), oxalic acid (uOx) and uric acid (uUa) in 73 male patients with primary calcium oxalate urolithiasis. According to the episodes of stone formation per year, we identified 51 recurrent stone formers (RSF) and 22 single stone formers (SSF). 20 normal adult males constituted the control group (C). uCa and uOx were higher in RSF than in C, but quite similar in SSF and RSF. The only difference between RSF and SSF was uCit, significantly lower (2.06 +/- 1.04 mmol/24 h) in RSF than in SSF (3.22 +/- 1.18 mmol/24 h, p less than 0.001) and in C (3.42 +/- 1.33 mmol/24 h, p less than 0.001). Hypocitraturia (uCit less than 1.5 mmol/24 h) was found in 16 of 51 RSF (31.4%) and in 1 of 22 SSF (4.5%). These data confirm that high levels of uCa and uOx represent a risk factor for lithogenesis, but also strongly indicate the low uCit excretion as the most important urinary abnormality accounting for the recurrence of calcium oxalate stones.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1528345     DOI: 10.1159/000186838

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  3 in total

1.  Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial.

Authors:  Shameez Allie-Hamdulay; Allen L Rodgers
Journal:  Urol Res       Date:  2005-05-04

2.  Stone composition and metabolic status.

Authors:  B S Bibilash; Adarsh Vijay; Y M Fazil Marickar
Journal:  Urol Res       Date:  2009-11-17

3.  Antilithiatic effects of crocin on ethylene glycol-induced lithiasis in rats.

Authors:  Fatemeh Abbasi Ghaeni; Bahareh Amin; Alireza Timcheh Hariri; Naser Tayyebi Meybodi; Hossein Hosseinzadeh
Journal:  Urolithiasis       Date:  2014-08-31       Impact factor: 3.436

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.